# Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia

> **NCT04739995** · PHASE4 · UNKNOWN · sponsor: **Fundació Sant Joan de Déu** · enrollment: 99 (actual)

## Conditions studied

- Randomized Controlled Trial

## Interventions

- **DRUG:** Low-dose naltrexone

## Key facts

- **NCT ID:** NCT04739995
- **Lead sponsor:** Fundació Sant Joan de Déu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2024-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04739995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04739995, "Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04739995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*